SADA
Live / Registered — Registered (as of 09 Mar 2021)
What this means for you
Registered since 09 Mar 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88889313
- Registration number
- 6286299
- Mark type
- Stylized text
- Filed
- 27 Apr 2020
- Published for opposition
- 22 Dec 2020
- Registered
- 09 Mar 2021
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer
- Class 042 — Scientific and technological services: Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of antibodies, and research and design relating thereto; industrial analysis and research services in the field of antibodies
Owner
- Y-mAbs Therapeutics, Inc, New York, NY, US
- Y-mAbs Therapeutics, Inc, New York, NY, US
- Y-mAbs Therapeutics, Inc, New York, NY, US
Prosecution history
- 09 Mar 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Mar 2021 — REGISTERED-PRINCIPAL REGISTER
- 22 Dec 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Dec 2020 — PUBLISHED FOR OPPOSITION
- 02 Dec 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Nov 2020 — ELECTRONIC RECORD REVIEW COMPLETE
- 13 Nov 2020 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 12 Nov 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Nov 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Nov 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Nov 2020 — ASSIGNED TO LIE
- 10 Sept 2020 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 20 Jul 2020 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 20 Jul 2020 — LETTER OF SUSPENSION E-MAILED
- 20 Jul 2020 — SUSPENSION LETTER WRITTEN